StanleyMoncriefLemonMD
Infectious Disease • Chapel Hill, NCProfessor, Medicine, University of North Carolina at Chapel Hill School of Medicine
Are you Dr. Lemon?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 43 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8.034 Burnett-Womack Cb 7292 Of No
# Univ
Chapel Hill, NC 27599Phone+1 919-843-1848Fax+1 919-843-7240
Summary
- Dr. Stanley Lemon, MD is an infectious disease specialist in Chapel Hill, North Carolina. He is currently licensed to practice medicine in North Carolina, Texas, and Maine. He is a Professor at University of North Carolina at Chapel Hill School of Medicine.
Education & Training
University of North Carolina HospitalsFellowship, Infectious Disease, 1975 - 1977- University of North Carolina HospitalsResidency, Internal Medicine, 1972 - 1975
University of Rochester School of Medicine and DentistryClass of 1972
Certifications & Licensure
NC State Medical License 1973 - 2025
TX State Medical License 2002 - 2012
ME State Medical License Active through 1984- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1987
Clinical Trials
Publications & Presentations
PubMed
- 1972 citationsModulation of hepatitis C virus RNA abundance by a liver-specific MicroRNACatherine L. Jopling, Min Kyung Yi, Alissa M. Lancaster, Stanley M. Lemon, Peter Sarnow
Science. 2005-09-02 - 117 citationsReplication of EBV in epithelial cells during infectious mononucleosisStanley M. Lemon, Lindsey M. Hutt, James E. Shaw, Jui Lien H. Li, Joseph S. Pagano
Nature. 1977-07-21 - 304 citationsStabilization of hepatitis C virus RNA by an Ago2–miR-122 complexTetsuro Shimakami, Daisuke Yamane, Rohit K. Jangra, Brian J. Kempf, Carolyn Spaniel
Proceedings of the National Academy of Sciences of the United States of America. 2012-01-17
Press Mentions
Preclinical Study Demonstrates Effective Oral Treatment Against Hepatitis a VirusJuly 6th, 2022- Key Player in Hepatitis A Infection ContaminationMay 31st, 2020
- Researchers Unearth Gatekeepers to Hepatitis A Virus Infection of Human CellsMay 28th, 2020
Grant Support
- Murine Model Of Hcv-Associated Human Liver CancerNational Cancer Institute2012
- Micro-Rna 122 And Chronic Hepatitis CNational Institute Of Allergy And Infectious Diseases2011–2012
- Hepatitis C And Tumor Suppressors In HepatocellularNational Cancer Institute2009–2011
- Intrahepatic IRF-3 And Nf-Kb Signaling And Interferon Responses In Hepatitis CNational Institute Of Allergy And Infectious Diseases2009–2010
- Administrative ServicesNational Institute Of Allergy And Infectious Diseases2006–2010
- Interferon Signaling And Cellular Permissiveness For Hepatitis C Virus (HCV)National Institute Of Allergy And Infectious Diseases2008–2009
- The Southeastern Cooperative Hepatitis C Research GroupNational Institute Of Allergy And Infectious Diseases2000–2009
- Hepatic Inflammation And Immunity 2008National Institute Of Allergy And Infectious Diseases2008
- Galveston National Laboratory OperationsNational Institute Of Allergy And Infectious Diseases2006–2008
- Interferon Signaling And Cellular Permissiveness For Hepatitis C VirusNational Institute Of Allergy And Infectious Diseases2007
- Southeastern Cooperative Hepatitis C Research GroupNational Center For Research Resources2003–2007
- Interferon Signaling And Cellular Permissiveness For HCVNational Institute Of Allergy And Infectious Diseases2005–2006
- Chimeric Virus Primate Model Of Hepatitis CNational Center For Research Resources2003–2006
- Administrative CoreNational Institute Of Allergy And Infectious Diseases2005
- Chimeric Virus Primate Model Of Hepatitis CNational Center For Research Resources2002–2005
- General Clinical Research CenterNational Center For Research Resources1999–2004
- National Biocontainment Laboratory (NBL)National Institute Of Allergy And Infectious Diseases2003
- Hepatic Inflammation And Immunity 2002National Institute Of Allergy And Infectious Diseases2002
- Selection Of Cell Culture-Adapted Hepatitis C RNANational Institute Of Allergy And Infectious Diseases1996–2002
- Extramural Research Facilities ConstructionNational Center For Research Resources2000
- Structure/Function Relations In HAV ReplicationNational Institute Of Allergy And Infectious Diseases1997–2000
- Rhinovirus Replicons As Vectors For Mucosal ImmunizationNational Institute Of Allergy And Infectious Diseases1997–2000
- Hepatic Inflammation And ImmunityNational Institute Of Allergy And Infectious Diseases1999
- Expansion And Renovation Of Utmb'S GcrcNational Center For Research Resources1999
- Southeastern Cooperative Hepatitis C Research GroupNational Institute Of Allergy And Infectious Diseases1997–1999
- Southeastern Cooperative Hepatitis C Research GroupNational Institute Of Allergy And Infectious Diseases1996
- Rhinovirus Replicons As Vectors For Mucosal ImmunizationNational Institute Of Allergy And Infectious Diseases1996
- Structure-Function Relations In HAV ReplicationNational Institute Of Allergy And Infectious Diseases1995–1996
- Infectious Disease Pathogenesis Research TrainingNational Institute Of Allergy And Infectious Diseases1993–1996
- Structure-Function Relations In HIV ReplicationNational Institute Of Allergy And Infectious Diseases1993–1994
- Immunogenic Epitopes Of HCV Envelope ProteinsNational Cancer Institute1992–1994
- Infectious Disease PathogenesisNational Institute Of Allergy And Infectious Diseases1988–1992
- University Of North Carolina AIDS Clinical Study GroupNational Institute Of Allergy And Infectious Diseases1987–1990
- Hepatitis Delta Infections In HemophiliacsNational Heart, Lung, And Blood Institute1986–1990
- Cloning &Sequencing Of Hepatitis A Virus CDNANational Institute Of Allergy And Infectious Diseases1986–1988
